Based on the presentation on 03.05.2016, the estimated top line results for phase II is due late 2018 (subject to change). You can find more details here:
http://actinogen.com.au/wp-content/uploads/2016/05/Investor-Presentation-03-May-2016.pdf
Also, they will start recruiting early 2017 for diabetes cognitive impairment in early 2017. with results around late 2018 as well. I guess these would be best case scenarios.
Based on the presentation on 03.05.2016, the estimated top line...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.004(8.89%) |
Mkt cap ! $111.1M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.0¢ | $788.3K | 18.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 155092 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 198568 | 2 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |